Mayo CRM-original iPSC-derived islet product in a retrievable, encapsulation device
Biobusiness Grant Recipient: Yasuhiro Ikeda, DVM, PhD
Grant Period: 2017-2018
Award Value: $100,000
Site: Mayo Clinic
Our product is MC-iLETS01, Mayo Center for Regenerative Medicine-original iPSC-derived islet cell product in a retrievable encapsulation device, for diabetes therapy. We will test its long-term safety/functionality in a mouse model of diabetes. The data will be used for our FDA pre-IND and IND applications.